A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Clinical trial NCT05955105 · UNKNOWN

Trial details

NCT number: NCT05955105
Sponsor: Innolake Biopharm
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Cervical Cancer Endometrial Cancer Triple Negative Breast Cancer Ovarian Cancer Soft Tissue Sarcoma Melanoma Nasopharyngeal Carcinoma Non Small Cell Lung Cancer Classic Hodgkin Lymphoma

Start date: 2023-07-25
Primary completion: 2026-01-25
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.